#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling


Autoři: Jason S. Nagati aff001;  Min Xu aff002;  Trent Garcia aff001;  Sarah A. Comerford aff003;  Robert E. Hammer aff004;  Joseph A. Garcia aff001
Působiště autorů: Department of Medicine, Columbia University Medical Center, New York, New York, United States of America aff001;  Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America aff002;  Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America aff003;  Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America aff004;  Department of Research, James J. Peters VA Medical Center, New York, New York, United States of America aff005
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0225105

Souhrn

The response to environmental stresses by eukaryotic organisms includes activation of protective biological mechanisms, orchestrated in part by transcriptional regulators. The tri-member Hypoxia Inducible Factor (HIF) family of DNA-binding transcription factors include HIF-2, which is activated under conditions of oxygen or glucose deprivation. Although oxygen-dependent protein degradation is a key mechanism by which HIF-1 and HIF-2 activity is regulated, HIF-2 is also influenced substantially by the coupled action of acetylation and deacetylation. The acetylation/deacetylation process that HIF-2 undergoes employs a specific acetyltransferase and deacetylase. Likewise, the supply of the acetyl donor, acetyl CoA, used for HIF-2 acetylation originates from a specific acetyl CoA generator, acetate-dependent acetyl CoA synthetase 2 (Acss2). Although Acss2 is predominantly cytosolic, a subset of the Acss2 cellular pool is enriched in the nucleus following oxygen or glucose deprivation. Prevention of nuclear localization by a directed mutation in a putative nuclear localization signal in Acss2 abrogates HIF-2 acetylation and blunts HIF-2 dependent signaling as well as flank tumor growth for knockdown/rescue cancer cells expressing ectopic Acss2. In this study, we report generation of a novel mouse strain using CRISPR/Cas9 mutagenesis that express this mutant Acss2 allele in the mouse germline. The homozygous mutant mice have impaired induction of the canonical HIF-2 target gene erythropoietin and blunted recovery from acute anemia. Surprisingly, Acss2 protein levels are dramatically reduced in these mutant mice. Functional studies investigating the basis for this phenotype reveal multiple protein instability domains in the Acss2 carboxy terminus. The findings described herein may be of relevance in the regulation of native Acss2 protein as well as for humans carrying missense mutations in these domains.

Klíčová slova:

Cell fusion – Euthanasia – Green fluorescent protein – Immunoblot analysis – Immunoblotting – Kidneys – Substitution mutation – Hematocrit


Zdroje

1. Luong A, Hannah VC, Brown MS, Goldstein JL. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem. 2000;275(34):26458–66. Epub 2000/06/14. doi: 10.1074/jbc.M004160200 M004160200 [pii]. 10843999.

2. Xu M, Nagati JS, Xie J, Li J, Walters H, Moon YA, et al. An acetate switch regulates stress erythropoiesis. Nat Med. 2014;20(9):1018–26. Epub 2014/08/12. doi: 10.1038/nm.3587 nm.3587 [pii]. 25108527; PubMed Central PMCID: PMC4159437.

3. Chen R, Xu M, Hogg RT, Li J, Little B, Gerard RD, et al. The acetylase/deacetylase couple CREB-binding protein/Sirtuin 1 controls hypoxia-inducible factor 2 signaling. J Biol Chem. 2012;287(36):30800–11. Epub 2012/07/19. doi: 10.1074/jbc.M111.244780 M111.244780 [pii]. 22807441; PubMed Central PMCID: PMC3436323.

4. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science. 2009;324(5932):1289–93. Epub 2009/06/06. 324/5932/1289 [pii] doi: 10.1126/science.1169956 19498162.

5. Chen R, Xu M, Nagati JS, Hogg RT, Das A, Gerard RD, et al. The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. PLoS One. 2015;10(2):e0116515. Epub 2015/02/18. doi: 10.1371/journal.pone.0116515 PONE-D-14-42884 [pii]. 25689462; PubMed Central PMCID: PMC4331492.

6. Bulusu V, Tumanov S, Michalopoulou E, van den Broek NJ, MacKay G, Nixon C, et al. Acetate Recapturing by Nuclear Acetyl-CoA Synthetase 2 Prevents Loss of Histone Acetylation during Oxygen and Serum Limitation. Cell Rep. 2017;18(3):647–58. Epub 2017/01/19. doi: 10.1016/j.celrep.2016.12.055 28099844; PubMed Central PMCID: PMC5276806.

7. Li X, Yu W, Qian X, Xia Y, Zheng Y, Lee JH, et al. Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy. Mol Cell. 2017;66(5):684–97 e9. doi: 10.1016/j.molcel.2017.04.026 28552616; PubMed Central PMCID: PMC5521213.

8. Chen R, Xu M, Nagati J, Garcia JA. Coordinate regulation of stress signaling and epigenetic events by Acss2 and HIF-2 in cancer cells. PLoS One. 2017;12(12):e0190241. Epub 2017/12/28. doi: 10.1371/journal.pone.0190241 29281714; PubMed Central PMCID: PMC5744998.

9. Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, et al. Acetate dependence of tumors. Cell. 2014;159(7):1591–602. Epub 2014/12/20. doi: 10.1016/j.cell.2014.11.020 25525877; PubMed Central PMCID: PMC4272450.

10. Mews P, Donahue G, Drake AM, Luczak V, Abel T, Berger SL. Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory. Nature. 2017;546(7658):381–6. doi: 10.1038/nature22405 28562591; PubMed Central PMCID: PMC5505514.

11. Gao X, Lin SH, Ren F, Li JT, Chen JJ, Yao CB, et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016;7:11960. doi: 10.1038/ncomms11960 27357947; PubMed Central PMCID: PMC4931325.

12. Starai VJ, Gardner JG, Escalante-Semerena JC. Residue Leu-641 of Acetyl-CoA synthetase is critical for the acetylation of residue Lys-609 by the Protein acetyltransferase enzyme of Salmonella enterica. J Biol Chem. 2005;280(28):26200–5. Epub 2005/05/19. doi: 10.1074/jbc.M504863200 15899897.

13. Nam YJ, Lubczyk C, Bhakta M, Zang T, Fernandez-Perez A, McAnally J, et al. Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development. 2014;141(22):4267–78. Epub 2014/10/26. doi: 10.1242/dev.114025 25344074; PubMed Central PMCID: PMC4302916.

14. Gulick AM, Starai VJ, Horswill AR, Homick KM, Escalante-Semerena JC. The 1.75 A crystal structure of acetyl-CoA synthetase bound to adenosine-5'-propylphosphate and coenzyme A. Biochemistry. 2003;42(10):2866–73. Epub 2003/03/12. doi: 10.1021/bi0271603 12627952.

15. Geffen Y, Appleboim A, Gardner RG, Friedman N, Sadeh R, Ravid T. Mapping the Landscape of a Eukaryotic Degronome. Mol Cell. 2016;63(6):1055–65. Epub 2016/09/13. doi: 10.1016/j.molcel.2016.08.005 27618491.

16. Costantini LM, Baloban M, Markwardt ML, Rizzo M, Guo F, Verkhusha VV, et al. A palette of fluorescent proteins optimized for diverse cellular environments. Nat Commun. 2015;6:7670. Epub 2015/07/15. doi: 10.1038/ncomms8670 26158227; PubMed Central PMCID: PMC4499870.

17. Jogl G, Tong L. Crystal structure of yeast acetyl-coenzyme A synthetase in complex with AMP. Biochemistry. 2004;43(6):1425–31. Epub 2004/02/11. doi: 10.1021/bi035911a 14769018.

18. Reger AS, Carney JM, Gulick AM. Biochemical and crystallographic analysis of substrate binding and conformational changes in acetyl-CoA synthetase. Biochemistry. 2007;46(22):6536–46. Epub 2007/05/15. doi: 10.1021/bi6026506 17497934; PubMed Central PMCID: PMC2536627.

19. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–W303. Epub 2018/05/23. doi: 10.1093/nar/gky427 29788355; PubMed Central PMCID: PMC6030848.


Článek vyšel v časopise

PLOS One


2019 Číslo 11
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

KOST
Koncepce osteologické péče pro gynekology a praktické lékaře
nový kurz
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Svět praktické medicíny 5/2023 (znalostní test z časopisu)

Imunopatologie? … a co my s tím???
Autoři: doc. MUDr. Helena Lahoda Brodská, Ph.D.

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#